RIFADIN 150 RIFADIN 150 (Rifadin 150 mg)
Generic Name: rifampin
Pill with imprint RIFADIN 150 RIFADIN 150 is Red, Capsule-shape and has been identified as Rifadin 150 mg. It is supplied by Aventis Pharmaceuticals.
Rifadin is used in the treatment of bartonellosis; haemophilus influenzae prophylaxis; endocarditis; legionella pneumonia; leprosy and belongs to the drug class rifamycin derivatives. Risk cannot be ruled out during pregnancy. Rifadin 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RIFADIN 150 RIFADIN 150
Rifadin
- Generic Name
- rifampin
- Imprint
- RIFADIN 150 RIFADIN 150
- Strength
- 150 mg
- Color
- Red
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Rifamycin derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aventis Pharmaceuticals
- Inactive Ingredients
-
corn starch,
D&C Red No. 28,
FD&C Blue No. 1,
FD&C Red No. 40,
magnesium stearate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00068-0510 | Upsher-Smith Laboratories Inc. |
| 52959-0461 (Discontinued) | H.J. Harkins Company, Inc. (repackager) |
More about Rifadin (rifampin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 1 Review
- Generic Availability
- Drug class: rifamycin derivatives
Patient resources
- Other brands
- Rimactane
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.